DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Ania Jastreboff - 1 Wegovy - 1 Dr - 1 Amit Khera - 1 National Institutes of Health’s Dr - 1 Tiffany M - 1 Powell - 1 Wiley - 1
Top related locs:
Philadelphia Powell
Top related orgs:
CNN - 1 Nordisk’s Wegovy - 1 American Heart Association - 1 Yale Obesity Research Center - 1 University of Texas Southwestern Medical Center Dallas - 1 National Institutes of Health’s - 1 New England - 1 of Medicine - 1

Search resuls for: "Amit Khera"


2 mentions found


☆ Trial confirms heart benefits of Wegovy, but is weight loss responsible – or something else?
  + stars: | 2023-11-11 | by ( Meg Tirrell | ) edition.cnn.com   time to read: +9 min
To cardiologist Dr. Steven Nissen of the Cleveland Clinic, who wasn’t involved in the trial but is leading a similar one of tirzepatide, those effects are all evidence of the benefits of weight loss. Tirzepatide has shown greater levels of weight loss than semaglutide in clinical trials, leading many, including Nissen, to hope it will show even stronger cardiovascular benefits. Importantly, participants didn’t have a history of diabetes; a previous trial had shown that treating people with diabetes with a GLP-1 drug, Ozempic, reduced their cardiovascular risk. The Wegovy trial showed that 569 of 8,803 people taking the drug had a heart attack or stroke or died from heart-related causes, or 6.5%. The amount of weight loss seen in the trial, 9.4%, was less than in other studies of Wegovy, which showed average weight loss closer to 15%.
Persons: Ania Jastreboff, Wegovy, Dr, Amit Khera, National Institutes of Health’s Dr, Tiffany M, Powell, Wiley, Eli Lilly, Steven Nissen, wasn’t, ” Nissen, “, Tirzepatide, Nissen, Michael Lincoff, Lincoff, ”, Jastreboff, Sanjay Gupta, hadn’t, “ semaglutide Organizations: CNN, Nordisk’s Wegovy, American Heart Association, Yale Obesity Research Center, University of Texas Southwestern Medical Center Dallas, National Institutes of Health’s, New England, of Medicine, US Food and Drug, Cleveland Clinic, Novo Nordisk, Cleveland, CNN Health Locations: Philadelphia, Powell
☆ Don’t bother with dietary supplements for heart health, study says
  + stars: | 2022-11-06 | by ( Jen Christensen | ) edition.cnn.com   time to read: +7 min
CNN —Six supplements that people commonly take for heart health don’t help lower “bad” cholesterol or improve cardiovascular health, according to a study published Sunday, but statins did. Some people believe that common dietary supplements – fish oil, garlic, cinnamon, turmeric, plant sterols and red yeast rice – will lower their “bad” cholesterol. The fatty deposits can block the flow of oxygen and blood that the heart needs to work and the blockage can lead to a heart attack or stroke. He calls these supplements “21st century snake oil.”In the United States, the Dietary Supplement and Health Education Act of 1994 sharply limited the US Food and Drug Administration’s ability to regulate supplements. “The good news, we know statins work,” Khera said.
0 next >>
Total: 2